The Services for the Preclinical Development of Therapeutic Agents contract offers a collection of preclinical services to support the development of promising therapeutic candidates, including those for lead identification and development, chemistry and manufacturing, in vitro microbiological services; in vitro and in vivo preclinical safety, toxicology and biokinetics; and pre-clinical development planning and evaluation.

Project Start
2006-09-15
Project End
2011-09-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$4,455,512
Indirect Cost